Skip to main content
Spectral Medical Inc. logo

Spectral Medical Inc. — Investor Relations & Filings

Ticker · EDT ISIN · CA8475771033 LEI · 529900085WMSYNZ2SM78 TSX Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2026-05-15 Proxy Solicitation & In…
Country CA Canada
Listing TSX EDT

About Spectral Medical Inc.

https://spectraldx.com/

Spectral Medical Inc. is a late-stage theranostic company focused on developing and commercializing products for the treatment of endotoxic septic shock (ESS). The company employs a unique theranostic approach that pairs a diagnostic test with a targeted therapy. The diagnostic component is the Endotoxin Activity Assay (EAA™), which measures endotoxin activity in the bloodstream to identify patients who may benefit from intervention. The therapeutic component is Toraymyxin™ (PMX), a hemoadsorption device designed for the removal of endotoxins. Spectral is currently advancing Toraymyxin™ through the TIGRIS Phase 3 clinical trial in pursuit of U.S. FDA approval, aiming to provide an individualized approach to critical sepsis care. PMX is already approved for therapeutic use in Japan and Europe.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Management Information Circular soliciting proxies for the annual general and special meeting of shareholders, containing voting procedures, director nominations, auditor reappointment, and other proposals. It is a proxy solicitation and information statement rather than a report or earnings release.
2026-05-15 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2026-05-08 English
Interim MD&A - English.pdf
Regulatory Filings
2026-05-08 English
News release - English.pdf
Regulatory Filings
2026-05-08 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 80% confidence The document is a news release providing an update on a Management Cease Trade Order (MCTO) related to delays in filing annual regulatory documents due to continuance issues. It is not the full annual report or MD&A, nor an earnings release, proxy statement, or other specialized filing. It serves as a general regulatory announcement to investors about compliance status and next steps. Therefore, it best fits the “Regulatory Filings” fallback category (RNS).
2026-04-01 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 75% confidence The document is a notice filed by Computershare to Canadian securities regulators providing logistical details for Spectral Medical Inc.’s upcoming Annual General and Special Meeting (record date, meeting date, location, proxy delivery, NAA requirements, security details). It is not a full proxy statement (no proposals or explanatory materials), nor an AGM presentation, earnings release, or other defined category. This type of administrative notice to regulators falls under the general regulatory filings category (RNS).
2026-04-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.